E. Demeter

426 total citations
9 papers, 332 citations indexed

About

E. Demeter is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Pharmacology. According to data from OpenAlex, E. Demeter has authored 9 papers receiving a total of 332 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Cellular and Molecular Neuroscience and 2 papers in Pharmacology. Recurrent topics in E. Demeter's work include Neurotransmitter Receptor Influence on Behavior (3 papers), Ion channel regulation and function (2 papers) and Cardiac electrophysiology and arrhythmias (2 papers). E. Demeter is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (3 papers), Ion channel regulation and function (2 papers) and Cardiac electrophysiology and arrhythmias (2 papers). E. Demeter collaborates with scholars based in Hungary and Germany. E. Demeter's co-authors include Zoltán Rihmer, M. Arató, E Somogyi, Mihály Arató, Kornélia Tekes, K. Magyar, Miklós Palkovits, László Tóthfalusi, K Majorossy and Zoltán Rihmer and has published in prestigious journals such as The British Journal of Psychiatry, Journal of Affective Disorders and Life Sciences.

In The Last Decade

E. Demeter

8 papers receiving 311 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Demeter Hungary 7 202 123 70 69 54 9 332
M Dumont Ireland 3 290 1.4× 97 0.8× 47 0.7× 103 1.5× 28 0.5× 5 454
Menachem Krakowski United States 8 261 1.3× 173 1.4× 66 0.9× 51 0.7× 65 1.2× 8 443
Mimi C. Roberts South Africa 9 122 0.6× 186 1.5× 26 0.4× 44 0.6× 26 0.5× 13 392
Candace N. White United States 8 199 1.0× 119 1.0× 25 0.4× 50 0.7× 102 1.9× 10 404
P. Courtet France 8 209 1.0× 113 0.9× 104 1.5× 50 0.7× 22 0.4× 20 407
G.N. Papadimitriou Greece 10 105 0.5× 96 0.8× 34 0.5× 41 0.6× 31 0.6× 30 284
Deirdre Montgomery United Kingdom 6 145 0.7× 155 1.3× 60 0.9× 28 0.4× 86 1.6× 6 298
Geoffrey R. Twitchell United States 11 153 0.8× 55 0.4× 162 2.3× 48 0.7× 23 0.4× 14 437
Edward P. Monnelly United States 9 185 0.9× 128 1.0× 39 0.6× 35 0.5× 62 1.1× 13 335
Claude Vanier Canada 5 147 0.7× 73 0.6× 128 1.8× 30 0.4× 23 0.4× 8 354

Countries citing papers authored by E. Demeter

Since Specialization
Citations

This map shows the geographic impact of E. Demeter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Demeter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Demeter more than expected).

Fields of papers citing papers by E. Demeter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Demeter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Demeter. The network helps show where E. Demeter may publish in the future.

Co-authorship network of co-authors of E. Demeter

This figure shows the co-authorship network connecting the top 25 collaborators of E. Demeter. A scholar is included among the top collaborators of E. Demeter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Demeter. E. Demeter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Gesierich, Anja, E. Demeter, Bastian Schilling, & Barbara Deschler-Baier. (2025). More than age: Impact of comorbidity and polypharmacy on immune-related adverse events, treatment discontinuation, and toxicity management in older patients receiving immune checkpoint inhibitors. Journal of Geriatric Oncology. 17(1). 102813–102813.
2.
Rihmer, Zoltán, et al.. (1990). Suicide in subtypes of primary major depression. Journal of Affective Disorders. 18(3). 221–225. 69 indexed citations
3.
Demeter, E., et al.. (1989). The asymmetry of 3H-imipramine binding may predict psychiatric illness. Life Sciences. 44(19). 1403–1410. 26 indexed citations
4.
Demeter, E., Kornélia Tekes, K Majorossy, M. Arató, & E Somogyi. (1988). Does 3H‐imipramine binding asymmetry indicate psychiatric illness?. Acta Psychiatrica Scandinavica. 77(6). 746–747. 7 indexed citations
5.
Arató, M., E. Demeter, Zoltán Rihmer, & E Somogyi. (1988). Retrospective psychiatric assessment of 200 suicides in Budapest. Acta Psychiatrica Scandinavica. 77(4). 454–456. 140 indexed citations
6.
Tekes, Kornélia, László Tóthfalusi, M. Arató, et al.. (1988). Is there a correlation between serotonin metabolism and 3H-imipramine binding in the human brain? Hemispheric lateralization of imipramine binding sites. Pharmacological Research Communications. 20. 41–42. 6 indexed citations
7.
Arató, Mihály, Kornélia Tekes, László Tóthfalusi, et al.. (1987). Serotonergic split brain and suicide. Psychiatry Research. 21(4). 355–356. 53 indexed citations
8.
Ríhmer, Z., et al.. (1985). Dexamethasone Suppression Test as an Aid for Selection of Specific Antidepressant Drugs in Patients with Endogenous Depression. Pharmacopsychiatry. 18(5). 306–308. 3 indexed citations
9.
Rihmer, Zoltán, et al.. (1984). The Dexamethasone Suppression Test in Psychotic versus Non-psychotic Endogenous Depression. The British Journal of Psychiatry. 145(5). 508–511. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026